Insight Molecular Diagnostics Inc. Common Stock Share Price
NASDAQ: IMDX
Live Insight Molecular Diagnostics Inc. Common Stock Share Price Chart
O H L
Insight Molecular Diagnostics Inc. Common Stock Performance Overview
Days Range
▼
$3.54Low
$3.90High
Markets Today
| Previous Close | $3.95 |
|---|---|
| Open | $3.74 |
| Volume | 197,736 |
| Day's Range | $3.54 - $3.90 |
| 52W Range | NA |
| Market Cap | $117.15 M |
Historical Performance
| 1M Returns | -7.71 |
|---|---|
| 3M Returns | -27.39 |
| 6M Returns | -9.82 |
| 1Y Returns | +17.21 |
| 5Y Returns | NA |
| 10Y Returns | NA |
Insight Molecular Diagnostics Inc. Common Stock Fundamentals
| Market Cap | $117.15 M |
|---|---|
| Dividend yield | N/A |
| PE Ratio | N/A |
| PEG Ratio | N/A |
| Revenue | $4.05 M |
| ROE TTM | N/A |
| EPS TTM | N/A |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | $-34.33 M |
| Profit Margin | -1238.52 |
| Market Cap | $117.15 M |
|---|---|
| Dividend yield | N/A |
| PE Ratio | N/A |
| PEG Ratio | N/A |
| Revenue | $4.05 M |
| ROE TTM | N/A |
| EPS TTM | N/A |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | $-34.33 M |
| Profit Margin | -1238.52 |
Insight Molecular Diagnostics Inc. Common Stock Profit & Loss
Quarterly
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Total Revenue + | $518.00 K | $260.00 K | $1.14 M | $32.00 K | $239.00 K |
| Gross Profit + | $338.00 K | $139.00 K | $496.00 K | $15.00 K | $157.00 K |
| Operating Income | -$9.84 M | -$11.05 M | -$23.43 M | -$10.33 M | -$11.40 M |
| EBITDA | -$9.28 M | -$10.46 M | -$8.27 M | -$9.70 M | -$10.74 M |
| Interest Expense | -$25.00 K | -$29.00 K | -$26.00 K | $0 | -$20.00 K |
| Depreciation | $559.00 K | $584.00 K | $15.16 M | $631.00 K | $665.00 K |
| Income Before Tax | -$9.74 M | -$10.85 M | -$22.95 M | -$4.29 M | -$11.26 M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income + | -$9.74 M | -$10.85 M | -$22.95 M | -$4.29 M | -$11.26 M |
| Net Profit Margin | -1880.69% | -4174.62% | -2015.36% | -13406.25% | -4711.3% |
Insight Molecular Diagnostics Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Share Capital | $367.96 M | $368.52 M | $369.21 M | $394.29 M | $394.94 M |
| Reserve & Surplus | -$366.87 M | -$377.72 M | -$400.68 M | -$404.98 M | -$416.24 M |
| Non-Current Liabilities | $42.77 M | $45.47 M | $45.15 M | $39.11 M | $40.46 M |
| Current Liabilities | $6.65 M | $7.66 M | $12.07 M | $12.01 M | $10.29 M |
| Total Liabilities | $49.42 M | $53.13 M | $57.22 M | $51.12 M | $50.74 M |
| Fixed Assets | $18.75 M | $18.75 M | $6.43 M | $6.45 M | $6.00 M |
| Current Assets | $26.84 M | $21.39 M | $15.31 M | $30.52 M | $20.54 M |
| Total Assets | $50.52 M | $43.94 M | $25.76 M | $40.43 M | $29.44 M |
Insight Molecular Diagnostics Inc. Common Stock Cash Flow
Quarterly
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Net Income | -$9.74 M | -$10.85 M | -$22.95 M | -$4.29 M | -$11.26 M |
| Operating Cash Flow | -$6.17 M | -$4.50 M | -$5.54 M | -$7.64 M | -$9.27 M |
| Investing Cash Flow | -$349.00 K | -$1.05 M | -$1.48 M | -$613.00 K | -$779.00 K |
| Financing Cash Flow | -$114.00 K | -$120.00 K | -$252.00 K | $24.70 M | -$564.00 K |
| Change in Cash | -$6.74 M | -$5.78 M | -$7.29 M | $16.44 M | -$10.63 M |
Insight Molecular Diagnostics Inc. Common Stock Return Calculator
The Insight Molecular Diagnostics Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$10,000
Invested Amount$10,000
Est. Returns$0
About Insight Molecular Diagnostics Inc. Common Stock
Insight Molecular Diagnostics Inc is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The Company's flagship technology quantifies a molecular biomarker known as donor-derived cell-free DNA (dd-cfDNA). It is also in the process of rebranding its RUO test kit, GraftAssure, as GraftAssureIQ, and rebranding its future in-vitro diagnostic (IVD) test kit as GraftAssureDx. The company geographically operates in the United States, the United Kingdom, Europe, and the Asia-Pacific regions, with maximum revenue generated from the USA.
Popular Stocks
FAQs
What is the share price of Insight Molecular Diagnostics Inc. Common Stock today?
Insight Molecular Diagnostics Inc. Common Stock (IMDX) share price as of September 18, 2026 is $3.75. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Insight Molecular Diagnostics Inc. Common Stock?
Yes, Indian Investors can invest in the Insight Molecular Diagnostics Inc. Common Stock (IMDX) Share by opening an international trading account with Angel One.
How can I purchase Insight Molecular Diagnostics Inc. Common Stock shares in India?
Purchasing Insight Molecular Diagnostics Inc. Common Stock (IMDX) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Insight Molecular Diagnostics Inc. Common Stock (IMDX) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Insight Molecular Diagnostics Inc. Common Stock?
Yes, you can purchase fractional shares of Insight Molecular Diagnostics Inc. Common Stock (IMDX) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Insight Molecular Diagnostics Inc. Common Stock?
The market capitalization of Insight Molecular Diagnostics Inc. Common Stock on September 18, 2026, is $117.15 M.
In which sector Insight Molecular Diagnostics Inc. Common Stock belongs?
Insight Molecular Diagnostics Inc. Common Stock operates in the null sector, specifically in the null industry.
What documents are required to invest in Insight Molecular Diagnostics Inc. Common Stock stocks?
In order to invest in Insight Molecular Diagnostics Inc. Common Stock (IMDX) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
